Guru Ownership Trend
Guru Analysis for Maze Therapeutics, Inc. (MAZE)
Maze Therapeutics, Inc. (MAZE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.6 M.
Top institutional holders include Jefferies Group and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $1.51 M net inflow during the quarter.
Recent activity highlights Jefferies Group who opened a new position. Conversely, Cliff Asness reduced exposure by 0.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Maze Therapeutics, Inc. (MAZE)
Major holders include Jefferies Group ($1.52 M), Cliff Asness ($733,399). According to the latest reported data, 2 tracked investment managers collectively hold approximately 82,861 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.51 M, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited MAZE. The total reported sell value was $4,838.05.
Yes, 1 managers opened new positions in MAZE, and 0 increased their existing holdings. The total reported buy value was $1.52 M.